Oklo (NYSE:OKLO) Sets New 52-Week Low - Here's Why

Key Points

• Oklo shares hit a new 52-week low of $31.02, down roughly 84% from their peak, amid concerns about the time and capital required to commercialize its nuclear and isotope projects, as well as broader weakness across nuclear stocks.
• The company continues to advance potential growth initiatives, including the Groves 2 Forge isotope-production facility and planned 20-year power-purchase agreements with Meta, but these remain subject to substantial execution and development risks.
• Analysts maintain a generally positive view, with a consensus “Moderate Buy” rating and average price target of $82.44, although several firms recently reduced their targets. Oklo also reported a quarterly EPS loss wider than expected despite revenue rising sharply year over year.

Oklo Inc. (NYSE:OKLO - Get Free Report)'s stock price reached a new 52-week low during trading on Wednesday. The stock traded as low as $31.02 and last traded at $31.8220, with a volume of 8,877,421 shares. The stock had previously closed at $32.21.

Key Headlines Impacting Oklo

Here are the key news stories impacting Oklo this week:

• Positive Sentiment: Oklo announced that it will advance its Groves 2 Forge isotope-production facility through the U.S. Department of Energy’s Nuclear Energy Launch Pad initiative. The project builds on the Groves Isotope Test Reactor and could support the company’s expansion into medical and other high-value isotopes. Oklo to Advance Groves 2 Forge as Part of U.S. Department of Energy’s Nuclear Energy Launch Pad Selection
• Positive Sentiment: Progress on reactor milestones, critical-material procurement and laboratory capabilities is strengthening Oklo’s medical-isotope strategy, giving investors another potential growth avenue beyond electricity generation. OKLO Builds on Groves Progress to Expand Isotope Business
• Neutral Sentiment: Oklo’s planned 20-year power-purchase agreements with Meta remain a potentially important commercial catalyst, but investors are weighing those future opportunities against the company’s early-stage development and execution risks. Oklo Dropped, So What Is Driving Attention Now?
• Negative Sentiment: The stock has fallen roughly 84% from its high and its market value has dropped below $6 billion. The new 52-week low reflects investor concerns that Oklo’s ambitious nuclear and isotope projects may take substantial time and capital to commercialize. Oklo Stock Hits a New 52-Week Low: Time to Buy?
• Negative Sentiment: Oklo is also being affected by weakness across nuclear stocks, as investors have recently reduced exposure to the sector after an earlier rally. This broader risk-off move has added selling pressure independent of Oklo-specific news. Nuclear Names Give Back a Month of Ground
• Negative Sentiment: General Counsel Vivek Narayanadas sold 364 shares under a pre-arranged Rule 10b5-1 plan to cover tax withholding on vested equity awards. The small, planned transaction is not a strong signal of deteriorating insider confidence, but it adds modestly to the negative headline flow. Oklo Insider Trading Activity

Wall Street Analyst Weigh In

Several research firms recently issued reports on OKLO. Canaccord Genuity Group cut their target price on Oklo from $125.00 to $100.00 and set a "buy" rating on the stock in a research report on Monday, August 10th. Barclays lowered their price target on Oklo from $82.00 to $76.00 and set an "overweight" rating for the company in a research report on Wednesday, July 22nd. Citigroup dropped their price target on Oklo from $76.00 to $57.50 and set a "neutral" rating on the stock in a research note on Monday, August 10th. HC Wainwright reiterated a "buy" rating and set a $90.00 price target on shares of Oklo in a research note on Monday, August 10th. Finally, Guggenheim initiated coverage on Oklo in a report on Thursday, June 25th. They issued a "neutral" rating on the stock. One research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $82.44.

Oklo Trading Down 1.2%

The business's 50-day simple moving average is $39.88 and its 200-day simple moving average is $50.84. The company has a market capitalization of $5.92 billion, a PE ratio of -33.85 and a beta of 1.20.

Oklo (NYSE:OKLO - Get Free Report) last released its quarterly earnings data on Friday, August 7th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.16) by ($0.12). The firm had revenue of $1.21 million for the quarter, compared to analyst estimates of $0.09 million. Oklo's revenue was up 11900.0% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.18) earnings per share. Sell-side analysts forecast that Oklo Inc. will post -1.02 EPS for the current fiscal year.

Insider Activity

In other Oklo news, Director John M. Jansen sold 6,354 shares of the company's stock in a transaction on Monday, September 14th. The shares were sold at an average price of $36.67, for a total value of $233,001.18. Following the sale, the director directly owned 6,000 shares of the company's stock, valued at approximately $220,020. This represents a 51.43% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Richard Bealmear sold 16,430 shares of the stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $38.76, for a total value of $636,826.80. Following the sale, the chief financial officer directly owned 455,976 shares in the company, valued at $17,673,629.76. This represents a 3.48% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 287,306 shares of company stock valued at $10,842,434 over the last quarter. Insiders own 12.70% of the company's stock.

Hedge Funds Weigh In On Oklo

Several institutional investors and hedge funds have recently modified their holdings of OKLO. Bank of America Corp DE increased its holdings in shares of Oklo by 55.3% during the 1st quarter. Bank of America Corp DE now owns 620,281 shares of the company's stock valued at $30,760,000 after purchasing an additional 220,976 shares in the last quarter. Bank of New York Mellon Corp lifted its stake in shares of Oklo by 1.2% in the 1st quarter. Bank of New York Mellon Corp now owns 516,886 shares of the company's stock valued at $25,632,000 after purchasing an additional 5,945 shares during the period. Swiss National Bank boosted its holdings in Oklo by 7.1% during the first quarter. Swiss National Bank now owns 324,900 shares of the company's stock worth $16,112,000 after buying an additional 21,400 shares in the last quarter. Rockefeller Capital Management L.P. boosted its holdings in Oklo by 427.1% during the fourth quarter. Rockefeller Capital Management L.P. now owns 171,128 shares of the company's stock worth $12,280,000 after buying an additional 138,659 shares in the last quarter. Finally, Amundi increased its stake in shares of Oklo by 59.0% in the 1st quarter. Amundi now owns 164,824 shares of the company's stock valued at $8,174,000 after purchasing an additional 61,161 shares in the last quarter. Institutional investors and hedge funds own 85.03% of the company's stock.

Oklo Company Profile

Oklo Inc is an advanced fission technology company developing compact nuclear power plants designed to provide reliable, carbon-free electricity. Its flagship Aurora powerhouse is a small-scale fission system intended to operate for extended periods and supply power directly to industrial, commercial, and other large energy users.

The company is also developing fuel-recycling capabilities to support the use of recovered nuclear fuel in advanced reactors. Oklo has pursued partnerships and regulatory work in the United States, including activities associated with the Idaho National Laboratory, and is initially focused on serving U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.